Alnylam Pharmaceuticals, Inc.

NASDAQ: ALNY
$135.21
-$2.04 (-1.5%)
Real time price as of June 4, 2020 10:34 am EDT
Thursday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, Applied Materials, Carnival, Dell, Karuna Therapeutics, Lowe's, Noble Energy, PayPal, Square, Target and...
Jon C. Ogg
Wednesday's top analyst upgrades, downgrades and initiations include Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, Johnson & Johnson, Replimune, Schlumberger and Transocean.
Jon C. Ogg
Alnylam Pharma and Regeneron Pharma shares dipped on Monday despite announcing a collaboration to discover, develop and commercialize new RNA interference therapeutics for a broad range of diseases.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Monday included Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix and Papa John's.
Lee Jackson
The top analyst upgrades, downgrades and other research calls from Tuesday include Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts and Zillow.
Jon C. Ogg
Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial and FDA updates in April.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Wednesday include Accenture, American Expresss, Cognizant Technology Solutions, FireEye, Mastercard, PayPal, Verizon and Visa.
Jon C. Ogg
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates for the rest of March.
Chris Lange
Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two weeks to start the year.
Chris Lange
With 2017 nearing an end, it is important to consider just what has happened. 24/7 Wall St. has screened 50 stocks that have risen 100% or more (some far more) in 2017.
Jon C. Ogg
The top analyst upgrades, downgrades and other research calls from Monday include AMD, Chevron, GM, Intel, Merck, Nokia and Under Armour.
Jon C. Ogg
Source: courtesy of Jon OggStocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one trend that has been proven time after time in this eight-year bull...
Jon C. Ogg
The top analyst upgrades, downgrades and other research calls from Wednesday include Axovant, Carnival, Micron Technology, Nike, SunPower, Vivint Solar and Walgreens.
Jon C. Ogg
The top analyst upgrades, downgrades and other research calls from Thursday include AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron Technology, Albermarle and Alnylam Pharmaceuticals.
Jon C. Ogg
Alnylam Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm gave an update on its late-stage trial in patients with hereditary ATTR amyloidosis with polyneuropathy.
Chris Lange